Advertisement
Screener

REGENERX BIOPHARMACEUTICALS, INC. Convertible Notes Payable, Current

REGENERX BIOPHARMACEUTICALS, INC. Convertible Notes Payable, Current

REGENERX BIOPHARMACEUTICALS, INC. had Convertible Notes Payable, Current of $1.17 million as of 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes Payable, Current

us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-05-15

  • 2023-03-31: Convertible Notes Payable, Current $1.17M.
  • 2022-12-31: Convertible Notes Payable, Current $0.00.
  • 2019-12-31: Convertible Notes Payable, Current $0.00.
  • 2019-09-30: Convertible Notes Payable, Current $0.00.
Period endConvertible Notes Payable, CurrentConvertible Notes Payable, Current as first filed
2023-03-31$1.17M
10-Q · filed 2023-05-15
2022-12-31$0.00
10-Q · filed 2023-05-15
2019-12-31$0.00
10-K · filed 2020-03-20
2019-09-30$0.00
10-Q · filed 2019-11-14
2019-06-30$0.00
10-Q · filed 2019-08-14
2019-03-31$0.00
10-Q · filed 2019-05-15
2018-12-31$54.75K
10-K · filed 2020-03-20
2018-09-30$51.44K
10-Q · filed 2018-11-14
2018-06-30$459.18K
10-Q · filed 2018-08-09
2018-03-31$439.35K
10-Q · filed 2018-05-15
2017-12-31$591.04K
10-K · filed 2019-03-29
$0.00
10-K · filed 2018-03-29
2017-09-30$300.00K
10-Q · filed 2017-11-14
2017-06-30$300.00K
10-Q · filed 2017-08-21
2017-03-31$300.00K
10-Q · filed 2017-05-15
2016-12-31$300.00K
10-K · filed 2018-03-29
2015-12-31$0.00
10-K · filed 2017-03-29
2014-09-30$299.28K
10-Q · filed 2014-11-10
2014-06-30$295.87K
10-Q · filed 2014-08-14
2014-03-31$292.49K
10-Q · filed 2014-05-15
2013-12-31$289.15K
10-Q · filed 2014-11-10
$10.85K
10-K · filed 2014-04-04
2013-09-30$14.27K
10-Q · filed 2013-11-18
2013-06-30$17.68K
10-Q · filed 2013-08-14
2013-03-31$21.06K
10-Q · filed 2013-05-15
2012-12-31$24.40K
10-K · filed 2014-04-04
2011-12-31$0.00
10-K · filed 2013-04-16